Cardiovascular disease prevention: matching evidence-based algorithms with individualized care

Area of Science:

• Cardiology
• Preventive Medicine
• Pharmacology

Background:

• The use of statins in primary prevention of cardiovascular disease is controversial.
• Statins effectively reduce cardiovascular events but carry risks, including new-onset diabetes.
• Balancing benefits and risks is crucial for appropriate statin prescription.

Purpose of the Study:

• To review current strategies for statin allocation in primary prevention.
• To compare evidence-based approaches with personalized risk assessment methods.
• To analyze the recommendations of current guidelines regarding statin use.

Main Methods:

• Literature review of studies on statin use in primary prevention.
• Analysis of different risk stratification tools: traditional risk factors, high-sensitivity C-reactive protein (hsCRP), coronary artery calcification (CAC), and genetic testing.
• Examination of current clinical practice guidelines.

Main Results:

• Statins demonstrate efficacy in reducing cardiovascular events across various risk levels.
• Personalized risk assessment tools (hsCRP, CAC, genetics) offer potential for refined patient selection.
• Current guidelines represent a hybrid approach, integrating evidence-based criteria with personalized risk factors.

Conclusions:

• Statin allocation in primary prevention requires careful consideration of individual patient profiles.
• A personalized approach, informed by advanced risk markers, may optimize statin therapy.
• Guidelines aim to navigate the complexities of statin use by blending established evidence with individualized assessment.